Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists
Grether, U., Benardeau, A., Benz, J., Binggeli, A., Blum, D., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Mohr, P., Puntener, K., Raab, S., Ruf, A., Schlatter, D.(2009) ChemMedChem 4: 951-956
- PubMed: 19326383 
- DOI: https://doi.org/10.1002/cmdc.200800425
- Primary Citation of Related Structures:  
3FEI, 3FEJ - PubMed Abstract: 
An X-ray-guided design approach led to the identification of a novel, balanced class of alpha-ethoxy-phenylpropionic acid-derived dual PPARalpha/gamma agonists. The series shows a wide range of PPARalpha/gamma ratios within a rather narrow structural space. Advanced compounds possess favorable physicochemical and pharmacokinetic profiles and show a high efficacy in T2D and dyslipidemia animal models.
Organizational Affiliation: 
Pharma Research, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. uwe.grether@roche.com